Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK.
Degenerative Diseases Program, Genetics, and Aging Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
Nat Commun. 2024 Oct 1;15(1):8508. doi: 10.1038/s41467-024-52772-x.
Immune surveillance by cytotoxic T cells eliminates tumor cells and cells infected by intracellular pathogens. This process relies on the presentation of antigenic peptides by Major Histocompatibility Complex class I (MHC-I) at the cell surface. The loading of these peptides onto MHC-I depends on the peptide loading complex (PLC) at the endoplasmic reticulum (ER). Here, we uncovered that MHC-I antigen presentation is regulated by ER-associated degradation (ERAD), a protein quality control process essential to clear misfolded and unassembled proteins. An unbiased proteomics screen identified the PLC component Tapasin, essential for peptide loading onto MHC-I, as a substrate of the RNF185/Membralin ERAD complex. Loss of RNF185/Membralin resulted in elevated Tapasin steady state levels and increased MHC-I at the surface of professional antigen presenting cells. We further show that RNF185/Membralin ERAD complex recognizes unassembled Tapasin and limits its incorporation into PLC. These findings establish a novel mechanism controlling antigen presentation and suggest RNF185/Membralin as a potential therapeutic target to modulate immune surveillance.
细胞毒性 T 细胞通过免疫监视消除肿瘤细胞和受细胞内病原体感染的细胞。这一过程依赖于主要组织相容性复合体 I 类 (MHC-I) 在细胞表面呈递抗原肽。这些肽加载到 MHC-I 上取决于内质网 (ER) 中的肽加载复合物 (PLC)。在这里,我们发现 MHC-I 抗原呈递受 ER 相关降解 (ERAD) 调控,这是一种清除错误折叠和未组装蛋白的重要蛋白质质量控制过程。一项无偏见的蛋白质组学筛选鉴定了 PLC 成分 Tapasin,它是将肽加载到 MHC-I 上所必需的,是 RNF185/膜联蛋白 ERAD 复合物的底物。RNF185/膜联蛋白的缺失导致 Tapasin 的稳态水平升高,并导致专业抗原呈递细胞表面的 MHC-I 增加。我们进一步表明,RNF185/膜联蛋白 ERAD 复合物识别未组装的 Tapasin 并限制其掺入 PLC。这些发现确立了一种控制抗原呈递的新机制,并表明 RNF185/膜联蛋白作为一种潜在的治疗靶点,可调节免疫监视。